ERG and prostate carcinoma: In this study, we hypothesize that multiple TMPRSS2:ERG fusion subtypes and additional low-prevalent TMPRSS2:ETS fusion genes are collectively more informative than any single marker alone in the noninvasive detection and stratification of clinically significant prostate cancer.